Royal Bank Of Canada Vincerx Pharma, Inc. Transaction History

Royal Bank Of Canada

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.0 - $0.0 $0 - $0	-1,009 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.0 - $0.0 $0 - $0	-2,896 Reduced 74.16%	1,009 $4,000
Q4 2021 Feb 14, 2022	BUY	$0.0 - $0.0 $0 - $0	2,327 Added 147.47%	3,905 $39,000
Q3 2021 Nov 15, 2021	BUY	$0.0 - $0.0 $0 - $0	1,256 Added 390.06%	1,578 $26,000
Q2 2021 Aug 16, 2021	BUY	$0.0 - $27.0 $0 - $8,694	322 New	322 $4,000

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $6.57M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.